An independent resource on ibogaine options, risks, and legal status.

Contact

Nubira welcomes corrections, questions, or feedback about its content and approach. If you have an update or a concern, we invite you to consult the site's editorial note on our about page to see how we handle sourcing and corrections before reaching out through our published channels.

How to reach Nubira

This site does not currently publish a direct email or contact form. Please check back for contact details; in the meantime, the about page explains Nubira’s editorial approach and how we accept corrections or source updates.

A short note on outreach

For readers in the Edison area seeking clarification about this site's scope: Nubira is an independent information resource and does not provide medical, legal, or clinical services. If your question concerns our editorial stance or sourcing, the best place to find that explanation is the page describing Nubira’s mission and editorial practices.

If you are checking claims about availability or legality beyond Edison, we sometimes reference broader resources and official statements elsewhere on the web; for instance, state-level discussions about ibogaine policy can be found in public advocacy pages such as the Texas governor ibogaine information portal at the Texas ibogaine policy site, which we consult only as a jurisdictional example rather than an endorsement.

If you want to revisit the homepage overview for context, this site’s front page provides the core framing and links to topic pages; return there any time by following the site label in the header or the inline link back to the main overview embedded on relevant pages. For editorial principles and sourcing, see the about page.

Disclosure

Nubira is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice.